Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand

Eleyna M Martin, Joanne C. Clark, Samantha J Montague, Luis A. Moran, Ying Di, Lily J. Bull, Luke Whittle, Florije Raka, Richard J. Buka, Idrees Zafar, Caroline Kardeby, Alexandre Slater, Steve P. Watson*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science